AgingResearch.News
Kidney Research and Clinical Practice

Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1

By Vladimir Petrovic, Vladislav A. Malkov, Andrew N. Billin, Show 4 more authorsAndrzej S. Królewski
Trial in peopleBiomarkers
Paper

The paper

Vladimir Petrovic, Vladislav A. Malkov, Andrew N. Billin, Show 4 more authorsAndrzej S. Królewski

Gilead Sciences (United States); Joslin Diabetes Center

Kidney Research and Clinical Practice, 4 Aug 2026

doi.org/10.23876/j.krcp.25.198PubMed 42548168

Related